HEALTH● LOWJul 10 · Jul 10, 2026, 11:29 AM
GSK partner Hansoh posts late-stage trial win for lung cancer drug in China
Seeking Alpha Tech
A partner of GSK, Hansoh, has successfully completed a late-stage trial for a lung cancer drug in China. This development marks progress in the pharmaceutical industry's efforts to treat lung cancer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH3h agoCONHESS: JOHESU mobilises health workers for showdown with FGVanguard NigeriaHEALTH3h agoEbola: No new cases in Nigeria as two suspected cases in North-east test negativePremium TimesHEALTH3h agoEbola scare in Adamawa: NCDC confirms negative testsVanguard NigeriaHEALTH4h agoEbola: Saudi Arabia suspends travel to Kenya, halts visa issuancePremium Times